Nir Gamliel, President and CEO

Nothing makes me happier than to apply my business experience to your scientific advances, and to see new treatments available for patients.

Mr. Nir Gamliel, is a business development professional with over two decades of experience working with international pharmaceutical, biotechnology, and medical device companies. Over the years Mr. Gamliel held senior management positions in Fortune 500, as well as small startup, companies. His expertise is in providing business development and strategic planning for life science companies. He has led partnering campaigns for products targeting diseases such as schizophrenia and acute myocardial infarction, non-invasive platforms for the diagnosis and monitoring of ischemic heart diseases, and computational tools for genomic analysis. During his most recent position as Vice President of Business Development at BioLineRx, a drug development company, he led the company in achieving two major out-licensing deals valued at $650 million, and was a member of the management team that secured two IPO’s.

Mr. Gamliel collaborates with an international and diverse network of strategists, business leaders, scientists, researchers, analysts, and marketing and financial experts. Together they offer global business solutions to PharBeyond’s clients. These solutions incorporate targeted business strategies into product and technology development plans, and licensing or collaborative agreements with global pharmaceutical, biotechnology or medical device companies.
top